Cardiotoxicity and Cardiac Monitoring Among Anthracycline-Treated Cancer Patients: A Retrospective Cohort Study.
Hadeel A AlKofideLamya S AlnaimNora AlorfWard AlessaGhada BawazeerPublished in: Cancer management and research (2021)
In this study, there was a high incidence of anthracyclines cardiotoxicity and poor compliance with cardiac monitoring recommendations for cancer patients on anthracyclines, which underscores acute and chronic cardiotoxicity in this population.